First report of emicizumab use in a female patient with severe hemophilia A

Blood Adv. 2020 Jul 14;4(13):2950-2952. doi: 10.1182/bloodadvances.2020002364.

Abstract

  1. This is the first report of successful use of emicizumab in a female patient with severe hemophilia A.

MeSH terms

  • Antibodies, Bispecific* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Female
  • Hemophilia A* / drug therapy
  • Humans

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • emicizumab